Scientists, public health leaders call for coordination in HIV prevention researchFebruary 26, 2007HIV prevention research was responsible for the recent revelation that male circumcision can play an important role in protecting men from infection with the deadly virus. But according to a new study funded by an independent coalition of public and private sector scientists and public health leaders, research is hampered by gaps in some areas of research and duplication in others. The group recommends the establishment of a neutral body to set priorities for research and promote collaboration without undermining the flexibility needed for scientific endeavor. "The rate of new HIV infections threatens to dwarf whatever progress has been made in improving treatment in recent years," said Veronica Miller, PhD, director of the Forum for Collaborative HIV Research, which is based at George Washington University's School of Public Health and Health Services in Washington DC. "This obligates the prevention research community to pull together, consolidate individual agendas, and prioritize according to what is most likely to succeed and can be realistically implemented." The new report, entitled A New Era for HIV Prevention?, arrives at a pivotal time for HIV prevention research. Results from some interventions, such as male circumcision, are showing great potential to lower the risk of infection. Meanwhile, an estimated 4.3 million people become newly infected with HIV each year.
Today, there are a number of promising HIV prevention interventions actively being studied, including male circumcision, microbicides, female-initiated barrier methods, HSV-2 treatment, pre-exposure prophylaxis, and treatment of the index partner, in addition to vaccines. Forum leaders remain optimistic that many of these interventions—either on their own or in combination with something else—will turn out to be powerful tools to fight HIV infection. With multiple lines of HIV prevention intervention research approaching Phase III studies, Forum leaders say the HIV prevention research field will need to find ways to: - Support the sustainable capacity of clinical trial sites; - Fill gaps in scientific knowledge; - Promote coordination among researchers and donors without stifling innovation; - Engage host communities to take ownership of clinical trials; - Prepare for effective global delivery of prevention interventions. "You are going into a community where you have to find people who are not yet infected but who are willing to be tested and participate in clinical trials. Unless there is community ownership, it is not going to happen," says Miller. The group recommends creation of a neutral planning mechanism, which could set priorities for research and promote collaboration without undermining the flexibility needed for scientific endeavor. Such a planning organization would attempt to reach out to a diverse group of stakeholders, including vaccine researchers, and would facilitate design and testing of combination products, share information, connect donors and stakeholders, fill knowledge gaps, reduce duplication in the research agenda, and make recommendations for choices regarding use of scarce resources. "This is an exciting time for HIV prevention research—we have more promising leads for effective new prevention tools than ever before. All those involved, from researchers to community leaders, must work together to accelerate this urgently needed research," says Nicholas Hellmann, MD, interim director for HIV and TB at the Bill & Melinda Gates Foundation. "This report answers the question of what we will need to do to enhance the next steps for research," says Ward Cates, MD, president of research at Family Health International and co-chair of the Biomedical Interventions HIV Prevention Working Group. "The field of HIV prevention is just like all other fields of research. It's a continual work in progress that needs coordinated oversight to optimize the outcomes." Forum for Collaborative HIV Research | |||||||||||||||||||||
|
Related Prevention Research News Articles African-Americans have unique lung cancer risks from chronic obstructive pulmonary disease Scientists at the M.D. Anderson Cancer Center have developed a risk prediction assessment for lung cancer specifically for African Americans that suggests a greater risk from chronic obstructive pulmonary disease (COPD). College freshmen: pain killers and stimulants less risky than cocaine; more risky than marijuana First year college students believe that occasional nonmedical use of prescription pain killers and stimulants is less risky than cocaine, but more risky than marijuana or consuming five or more alcoholic beverages every weekend. Researchers identify cancer preventive properties in common vitamin supplement Early laboratory research has shown that resveratrol, a common dietary supplement, suppresses the abnormal cell formation that leads to most types of breast cancer, suggesting a potential role for the agent in breast cancer prevention. Pediatrics review of underage drinking prevention programs led by ISU's Spoth Underage drinking is a national concern that led the U.S. surgeon general to issue a "Call to Action to Prevent and Reduce Underage Drinking" last year. Now, a new report by an Iowa State University researcher assesses the effectiveness of underage drinking prevention programs and provides a better idea of how to achieve key goals outlined by the surgeon general. Drinking at an early age can lead to later alcohol dependence An early age at onset of drinking (AOD) is a strong predictor of subsequent alcohol dependence (AD). Following through on previous research that found substantial increases in drinking and AD among women born between 1944 - 1983, compared to women born between 1934 - 1943, this study examined the influence of AOD. New data show benefit of finasteride in preventing prostate cancer A comprehensive re-evaluation of the largest prostate cancer prevention study ever completed produced new findings suggesting that men and their doctors should consider a more aggressive approach that includes finasteride to prevent the development of prostate cancer. Leading experts investigate Shaken Baby Syndrome Shaken Baby Syndrome (SBS), also known as childhood neurotrauma or inflicted traumatic brain injury, is the leading cause of death from childhood maltreatment. Pediatricians alerted to the developmental nature of underage drinking in special journal supplement In a special supplement to Pediatrics, edited and sponsored by the National Institute on Alcohol Abuse and Alcoholism (NIAAA), physicians will have access in one place to the reviews and analyses of current research on biological, behavioral, and environmental changes during childhood and adolescence that foster the initiation, maintenance, and acceleration of illegal use of alcohol by underage youth. Early neglect predicts aggressive behavior in children Children who are neglected before their second birthday display higher levels of aggressive behavior between ages 4 and 8, according to a University of North Carolina at Chapel Hill study, published today in the journal Pediatrics. Stanford researcher criticizes FDA plans to reduce oversight of off-label drug use Proposed guidelines from the U.S. Food and Drug Administration would allow companies to market more drugs for unapproved uses and are a step in the wrong direction, said a researcher from the Stanford University School of Medicine. More Prevention Research News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||